Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, ...
Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks: Cambridge, Massachusetts Tuesday, Septembe ...
Developed Proteomic Aging Clocks: Analyzing 12-week longitudinal Olink proteomic data from 42 IPF patients, six aging clock models (including ProtAge, OrganAge, and PAC) independently developed by the ...
Researchers from Insilico Medicine and an international group of academic collaborators have applied six independently ...
Dr. Remington Nevin is a the director of a county health department in Michigan but is poised to become Michigan's very own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results